Verigen, Italchimici SpA deal

Italchimici received a non-exclusive license to develop and market Verigen's PASSTNF-alpha

Read the full 119 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE